An update on papillary microcarcinoma

Current Opinion in Oncology

Volumn 21, Issue 1, 2009, Pages 1-4

  Grodski, Simon ^a   Delbridge, Leigh ^b,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Cancer incidence; Cancer recurrence; Mesh; Papillary microcarcinoma; Thyroid cancer

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE; IODINE 131; KI 67 ANTIGEN; LEVOTHYROXINE; PROTEIN P53; TUMOR MARKER;

ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURGERY; EVIDENCE BASED MEDICINE; HUMAN; PAPILLARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROIDECTOMY; TUMOR VOLUME; ULTRASOUND;

CARCINOMA, PAPILLARY; EVIDENCE-BASED MEDICINE; HUMANS; PROGNOSIS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149260121     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32831a9a82     Document Type: Review

References (19)

1. Lloyd R, De Lellis R, Heitz P, Eng C. World Health Organization Classification of Tumours: pathology and genetics of tumours of the endocrine organs. Lyon, France: IARC Press; 2004.
2. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126:226-231.
3. Ross DS. Nonpalpable thyroid nodules-managing an epidemic. J Clin Endocrinol Metab 2002; 87:1938-1940.
4. Greene F, Page D, Flemming I, et al. AJCC Cancer Staging Handbook. 6th ed. New York: Springer-Verlag; 2002.
5. Burgess JR, Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 2006; 16:47-53.
6. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295:2164-2167.
7. Leenhardt L, Grosclaude P, Cherie-Challine L. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 2004; 14: 1056-1060.
8. Grodski S, Brown T, Sidhu S, et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery (in press). This retrospective review of the incidence of thyroid cancer in retrosternal goitre over 40 years demonstrates a significant increase in the incidence of thyroid cancer which is associated with an increase in the number of tissue blocks being examined by the pathologists.
9. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13:381-387.
10. British Thyroid Association. Guidelines for the management of thyroid cancer. 2007. http://www.british-thyroid-association.org/Thyroid-cancer- guidelines- 2007.pdf.
11. Pellegrrti G, Scollo C, Lumera G, et al. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004; 89:3713-3720.
12. Hay I, Hutchinson M, Reinalda M, et al. Papillary thyroid microcarcinoma: a study of 900 cases treated at one institution during a 60 year period. Surgery (in press). This large series of PMC over 60 years with long follow-up considerably adds to our understanding of the natural histroy of PMC. It once again highlights the excellent prognosis and examines different treatments and their influence on recurrence.
13. Noguchi S, Yamashita H, Uchino S, Watanabe S. Papillary microcarcinoma. World J Surg 2008; 32:747-753. This is the largest published series of PMC with long follow-up and considerably adds to our understanding of the natural history of PMC. It once again highlights the excellent prognosis and examines different treatments and their influence on recurrence.
14. Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br J Surg 1996; 83:1674-1683.
15. Lim DJ, Baek KH, Lee YS, et al. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid 2007; 17: 883-888.
16. Jeong HS, Chung M, Baek CH, et al. Can [18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas? Laryngoscope 2006; 116:2133-2137.
17. Cooper DS, Doherty GM, Haugen BR, et al. Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16:1-33.
18. Perros P, Clarke SEM, Franklyn J et al. In: Perros P, editor. Guidelines for the management of thyroid cancer. 2nd ed. London: Royal College of Physicians of London; 2007.
19. Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154:787-803.